Article
Prognostic value of loss of heterozygosity and sub-cellular localization of SMAD4 varies with tumor stage in colorectal cancer.
Oncotarget - 21 Mar 2017
Jia Xu, Shanmugam Chandrakumar, Paluri Ravi K, Jhala Nirag C, Behring Michael P, Katkoori Venkat R, Sugandha Shajan P, Bae Sejong, Samuel Temesgen, Manne Upender
Abstract excerpt
BACKGROUND: Although loss of heterozygosity (LOH) at chromosome location 18q21 and decreased expression of SMAD4 in invasive colorectal cancers (CRCs) correlate with poor patient survival, the prognostic value of LOH at 18q21 and sub-cellular localization of SMAD4 have not been evaluated in relation to tumor stage. METHODS: Genomic DNA samples from 209 formalin-fixed, paraffin-embedded sporadic CRC tissues and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
